(Q46727017)

English

Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

1 reference

based on heuristic

inferred from title

7

object named as

Jan K Buitelaar

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

author name string

Joris C Verster

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Evelijne M Bekker

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Marlise de Roos

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Anita Minova

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Erik J E Eijken

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

J J Sandra Kooij

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

J Leon Kenemans

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Marinus N Verbaten

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Berend Olivier

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Edmund R Volkerts

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

language of work or name

0 references

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

22

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

230-237

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

The Efficacy of 2 Different Dosages of Methylphenidate in Treating Adults with Attention-Deficit Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

A review of the economic burden of ADHD

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Comparative perceptions of driver ability--a confirmation and expansion

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Driving performance under the influence of drugs: rationale for, and application of, a new test

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Diazepam impairs lateral position control in highway driving.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082946

21 January 2018

Identifiers

10.1177/0269881107082946

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18308788

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46727017&oldid=2128483482"